Gainers

• Trevi Therapeutics, Inc. (NASDAQ:TRVI) rose 32.5% to $1.59 in pre-market trading after the company filed Friday to withdraw its offering of shares.
• Nutriband Inc. (NASDAQ:NTRB) shares rose 12.1% to $7.51 in pre-market trading after dropping over 14% on Friday.
• Avadel Pharmaceuticals plc (NASDAQ:AVDL) rose 10% to $11.00 in pre-market trading.
• Liquidia Corporation (NASDAQ:LQDA) rose 9.9% to $3.00 in pre-market trading after the company received favorable ruling in Inter Partes Review against United Therapeutics patent.
• Borr Drilling Limited (NYSE:BORR) shares rose 7.7% to $1.11 in pre-market trading.
• Camber Energy, Inc. (NYSE:CEI) rose 7.6% to $1.84 in pre-market trading after declining 4% on Friday.
• Yumanity Therapeutics, Inc. (NASDAQ:YMTX) rose 6.9% to $9.80 in pre-market trading.
• U.S. Well Services, Inc. (NASDAQ:USWS) rose 6.7% to $2.56 in pre-market trading.
• Luokung Technology Corp. (NASDAQ:LKCO) rose 6.3% to $1.18 in pre-market trading after declining over 3% on Friday.
• AIkido Pharma Inc. (NASDAQ:AIKI) shares rose 5.6% to $0.9185 in pre-market trading. HC Wainwright & Co. initiated coverage on AIkido Pharma with a Buy rating and announced a price target of $2.
• Matinas BioPharma Holdings, Inc. (NASDAQ:MTNB) rose 4.7% to $1.11 in pre-market trading.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Cellectis S.A. (NASDAQ:CLLS) fell 6% to $8.57 in pre-market trading after tumbling 24% on Friday. Baird downgraded Cellectis from Outperform to Neutral and lowered the price target from $39 to $10.
• Valneva SE (NASDAQ:VALN) fell 5.2% to $27.89 in pre-market trading after gaining around 3% on Friday.
• Romeo Power, Inc. (NYSE:RMO) fell 4.5% to $4.43 in pre-market trading. Romeo Power recentlu leased a new Class A, state-of-the-art headquarters and manufacturing facility in Cypress, California.
• Aditxt, Inc. (NASDAQ:ADTX) shares fell 4% to $1.70 in pre-market trading. Aditxt recently agreed to acquire AiPharma Global Holdings LLC, focused on discovering, developing, and commercializing antiviral therapies.